Suppr超能文献

新生儿重症监护病房中粪便中的产气荚膜梭菌、产时抗生素与胃肠道症状

Clostridium perfringens in stool, intrapartum antibiotics and gastrointestinal signs in a neonatal intensive care unit.

作者信息

Ahtonen P, Lehtonen O P, Kero P, Eerola E, Hartiala K

机构信息

Department of Pediatrics, Turku University Central Hospital, Finland.

出版信息

Acta Paediatr. 1994 Apr;83(4):389-90. doi: 10.1111/j.1651-2227.1994.tb18125.x.

Abstract

In 1989, we observed in our neonatal intensive care unit (NICU), an increased number of infants with gastrointestinal signs, including five cases of necrotizing enterocolitis. Clostridium perfringens was found in 26% of newborns (n = 168) and was associated significantly with the occurrence of flatulence, distended abdomen, foul-smelling stools, diarrhea and blood in stool (all p < 0.001). C. difficile was found in 17% of the newborns (n = 72). Cesarean section, low gestational age and low birth weight were significantly associated with C. perfringens in stools (all p < 0.001). Treatment with antibiotics was not associated with occurrence of C. perfringens. However, in infants with C. perfringens, intrapartum antibiotics were associated with increased appearance of abdominal distension (p < 0.05). Thus the antibiotics, which disturb primary colonization, may also favor the pathogenic role of opportunistic gut bacteria, such as C. perfringens.

摘要

1989年,我们在新生儿重症监护病房(NICU)观察到,出现胃肠道症状的婴儿数量有所增加,其中包括5例坏死性小肠结肠炎。在26%的新生儿(n = 168)中发现了产气荚膜梭菌,且其与肠胃胀气、腹部膨胀、大便恶臭、腹泻和便血的发生显著相关(所有p < 0.001)。在17%的新生儿(n = 72)中发现了艰难梭菌。剖宫产、低胎龄和低出生体重与粪便中产气荚膜梭菌显著相关(所有p < 0.001)。抗生素治疗与产气荚膜梭菌的发生无关。然而,在产气荚膜梭菌感染的婴儿中,产时使用抗生素与腹胀出现频率增加有关(p < 0.05)。因此,干扰初始定植的抗生素可能也有利于诸如产气荚膜梭菌等机会性肠道细菌发挥致病作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验